Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp Regulatory News (PEYS)

Share Price Information for Partners Grp (PEYS)

Share Price is delayed by 15 minutes
Get Live Data
614.00    1.00 (0.16%)
Bid:
598.00
Ask:
614.00
Spread: 16.00 (2.676%)
Market Cap: £412.35m
PEYS Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp Share Chart

PGPE Ltd publishes July NAV

4 Sep 2024 07:00

RNS Number : 8560C
Partners Group Private Equity Ltd
04 September 2024
 

(LSE: PEYS/PEY)

 

Partners Group Private Equity Limited

 

PGPE Ltd publishes July NAV

 

 

· NAV decreased by 0.7% to EUR 14.28 per share; total net assets at EUR 987.40 million

· Revaluations (-0.4%, of which -0.2% was due to the movement in the listed share price of Galderma), and currency movements (-0.4%) detracted from NAV

· PGPE Ltd invested EUR 2.2 million and received distributions of EUR 1.7 million

 

In July, the net asset value of PGPE Ltd decreased by 0.7%. The performance was partly driven by Galderma, a Switzerland-headquartered pharmaceutical company specializing in dermatological treatments and skin care products. The company is listed on the SIX Swiss Exchange and its share price saw a decline at the end of the month as a result of market compression. Nevertheless, the share price has since increased with the company announcing in August that it has signed a memorandum of understanding with L'Oréal to work towards a new research and development (R&D) collaboration. This would take the form of a scientific partnership focused on complementary research projects which could develop advanced, future-proof technologies with direct applications in the field of dermatology.

 

After the month's end, the Company held its semi-annual webcast to update investors on the recent developments of the portfolio. The recording is available under the following link.

 

Further information is available in the monthly report, which can be accessed via: https://www.partnersgroupprivateequitylimited.com/en/investor-relations/financial-reports/

 

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd (formerly Princess Private Equity Holding Limited) is an investment holding company founded in 1999 and domiciled in Guernsey. It invests in private equity direct investments. PGPE Ltd is managed in its investment activities by Partners Group, a global private markets investment management firm with USD 149 billion in investment programs under management in private markets, of which USD 76 billion is in private equity. PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield. PGPE Ltd is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

Investor relations contact:

Andreea Mateescu

Phone: +41 41 784 66 73

E-mail: andreea.mateescu@partnersgroup.com

 

Media relations contact:

Jenny Blinch

Phone: +41 41 784 65 26

E-mail: jenny.blinch@partnersgroup.com

 

Registered Number: 35241 LEI: 54930038LU8RDPFFVJ57

Notes:

1. Note that references in this announcement to Partners Group Private Equity Limited have been abbreviated to "PGPE Ltd" or "Company". References to Partners Group AG have been abbreviated to "Partners Group" or "Investment Manager".

2. This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Partners Group Private Equity Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

3. This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of PGPE Ltd' website nor the contents of any website accessible from hyperlinks on PGPE Ltd' website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGGLKDRGDZG
Date   Source Headline
2nd Oct 20237:00 amRNSTotal Voting Rights
18th Sep 20237:15 amEQSJPMorgan European Discovery Trust: A balanced trust targeting a world-beating market
18th Sep 20237:00 amEQSUtilico Emerging Markets Trust: Emerging market growth opportunities at a discount
13th Sep 20237:00 amEQSMurray International Trust (MYI): Business as usual at Murray International
7th Sep 20237:15 amEQSEdison issues update on Princess Private Equity Holding (PEY)
1st Sep 20237:00 amRNSPrincess publishes July NAV
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 202310:48 amRNSHolding(s) in Company
30th Aug 20239:40 amRNSHolding(s) in Company
24th Aug 20237:00 amRNSPrincess publishes Half-Year Report 2023
1st Aug 20239:55 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSPrincess publishes June NAV
25th Jul 20237:00 amRNSSave the date for Q2 2023 results announcement
4th Jul 20237:00 amRNSNAV increases by 2.0% in May
3rd Jul 20237:00 amRNSTotal Voting Rights
26th Jun 20233:00 pmRNSHolding(s) in Company
23rd Jun 202312:00 pmRNSResult of AGM
22nd Jun 20235:00 pmRNSWithdrawal of directors’ nominations for AGM
1st Jun 20237:00 amRNSPrincess publishes April NAV
1st Jun 20237:00 amRNSTotal Voting Rights
23rd May 20237:00 amRNSPrincess Q1 2023 results presentation
19th May 20235:03 pmRNSHolding(s) in Company
19th May 20237:00 amRNSNotice of Annual General Meeting
2nd May 20237:00 amRNSNAV increases by 0.3% in March
2nd May 20237:00 amRNSTotal Voting Rights
25th Apr 20237:00 amRNSSave the date for Q1 2023 results announcement
21st Apr 20234:10 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSNAV increases by 0.4% in February
21st Mar 20237:00 amRNSPrincess publishes Annual Report 2022
2nd Mar 20233:30 pmRNSHolding(s) in Company
1st Mar 20239:45 amRNSNAV increases by 0.7% in January
1st Mar 20237:00 amRNSTotal Voting Rights
28th Feb 20237:00 amRNSPrincess Q4 2022 Updates
10th Feb 20234:40 pmRNSSecond Price Monitoring Extn
10th Feb 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 20239:50 amRNSNAV increases by 3.4% in December
1st Feb 20237:00 amRNSTotal Voting Rights
30th Jan 20233:24 pmRNSSave the date for Q4 2022 results announcement
5th Jan 20239:00 amRNSNAV increases by 0.5% in November
3rd Jan 20237:00 amRNSTotal Voting Rights
1st Dec 20227:00 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSPrincess publishes October NAV
29th Nov 20227:58 amRNSEdison issues update on Princess Private Equity
22nd Nov 20227:00 amRNSPrincess Q3 2022 Results Presentation
9th Nov 20227:00 amRNSPrincess Q3 2022 Results Presentation
2nd Nov 20227:00 amRNSGuidance on second interim dividend for FY 2022
1st Nov 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.